Telemedicine could yield $6B per year in savings

Telemedicine has the potential to deliver more than $6 billion in healthcare savings per year to U.S. companies, according to global analytics company Towers Watson.

Managing such savings would require all employees and their dependents to use the technology-enabled interactions in place of face-to-face visits to the doctor, urgent care center or emergency room for appropriate medical problems, according to the analysis.

In a survey 1,000 U.S. employers, 37 percent said that by 2015 they expect to offer their employees telemedicine consultations as a low-cost alternative to emergency room or physician office visits for nonemergency health issues, according to Towers. Another 34 percent are considering offering telemedicine for 2016 or 2017. Overall, the percentage of employers offering telemedicine is expected to rise from 22 percent to 37 percent, a 68 percent increase.

“While this analysis highlights a maximum potential savings, even a significantly lower level of use could generate hundreds of millions of dollars in savings. Achieving this savings requires a shift in patient and physician mindsets, health plan willingness to integrate and reimburse such services, and regulatory support in all states,” said Allan Khoury, MD, a senior consultant at Towers Watson, in a statement.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.